1. Kawaguchi Y, Hanaoka J, Ohshio Y, Okamoto K, Kaku R, Hayashi K, et al.
Survival and prognostic factors in patients undergoing extended pulmonary
metastasectomy. Mol Clin Oncol. 2020;13(5):48. https://doi.org/10.3892/
mco.2020.2118.
2. Kadota K, Nitadori J, Sima CS, Ujiie H, Rizk NP, Jones DR, et al. Tumor spread
through air spaces is an important pattern of invasion and impacts the
frequency and location of recurrences after limited resection for small stage
I lung adenocarcinomas. J Thorac Oncol. 2015;10(5):806–14. https://doi.org/1
0.1097/JTO.0000000000000486.
3. Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, et al.
Histopathologic prognostic factors in resected colorectal lung metastases.
Ann Thorac Surg. 2005;79(1):278–82. https://doi.org/10.1016/j.athoracsur.2
004.06.096.
4. Shiono S, Ishii G, Nagai K, Murata Y, Tsuta K, Nitadori J, et al.
Immunohistochemical prognostic factors in resected colorectal lung
metastases using tissue microarray analysis. Eur J Surg Oncol. 2006;32(3):
308–9. https://doi.org/10.1016/j.ejso.2005.12.003.
5. Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, et al.
Predictive factors for local recurrence of resected colorectal lung
metastases. Ann Thorac Surg. 2005;80(3):1040–5. https://doi.org/10.1016/
j.athoracsur.2004.12.033.
6. Kepil N, Batur S, Goksel S. Immunohistochemical and genetic features of
mucinous and signet-ring cell carcinomas of the stomach, colon and
rectum: a comparative study. Int J Clin Exp Pathol. 2019;12(9):3483–91.
7. Lan YT, Chang SC, Yang SH, Lin CC, Wang HS, Jiang JK, et al. Comparison of
clinicopathological characteristics and prognosis between early and late
recurrence after curative surgery for colorectal cancer. Am J Surg. 2014;
207(6):922–30. https://doi.org/10.1016/j.amjsurg.2013.08.035.
8. Kawaguchi Y, Hanaoka J, Ohshio Y, Okamoto K, Kaku R, Hayashi K, et al.
Patient survival after surgical Management in Intrathoracic Pseudomyxoma
peritonei. Ann Surg Oncol. 2019;26(1):238–43. https://doi.org/10.1245/s1
0434-018-6991-7.
9. Dong Y, Zhou L, Zhao D, Li K, Liu Z, Che N, et al. MUC5AC enhances tumor
heterogeneity in lung adenocarcinoma with mucin production and is
associated with poor prognosis. Jpn J Clin Oncol. 2020;21:5742631.
10. Aronsson L, Bengtsson A, Toren W, Andersson R, Ansari D. Intraductal
papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: a
systematic review and meta-analysis. Int J Surg. 2019;71:91–9. https://doi.
org/10.1016/j.ijsu.2019.09.014.
Kawaguchi et al. BMC Cancer
(2021) 21:470
11. Stolnicu S, Hoang L, Soslow RA. Recent advances in invasive
adenocarcinoma of the cervix. Virchows Arch. 2019;475(5):537–49. https://
doi.org/10.1007/s00428-019-02601-0.
12. Chen RF, Tao X, Wu BB, Li J, Wang JY, Gu WY, et al. Mucinous borderline
ovarian tumors with and without intraepithelial carcinoma: differences in
clinicopathologic features and fertility results. J Obstet Gynaecol Res. 2020;
11(10):14210.
13. Ged Y, Chen YB, Knezevic A, Donoghue MTA, Carlo MI, Lee CH, et al.
Mucinous tubular and spindle-cell carcinoma of the kidney: clinical features,
genomic profiles, and treatment outcomes. Clin Genitourin Cancer. 2019;
17(4):268–74. https://doi.org/10.1016/j.clgc.2019.04.006.
14. Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, et al. Primary
mucinous carcinoma of thyroid gland with prominent signet-ring-cell
differentiation: a case report and review of the literature. Onco Targets Ther.
2018;11:1521–8. https://doi.org/10.2147/OTT.S158975 eCollection 2018.
15. Younes RN, Fares AL, Gross JL. Pulmonary metastasectomy: a multivariate
analysis of 440 patients undergoing complete resection. Interact Cardiovasc
Thorac Surg. 2012;14(2):156–61. https://doi.org/10.1093/icvts/ivr076.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Page 10 of 10
...
論文の公開元へ
